In conclusion, in the present study it has been shown that CXB, a COX-2 inhibitor, in combination with DOX, a chemotherapeutic drug, is able to induce MTC cell apoptosis and reduce tumor growth in vivo. The gene discussed is PTGS2; the disease is medullary thyroid gland carcinoma.